These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25377295)

  • 1. Histopathology of excised midurethral sling mesh.
    Hill AJ; Unger CA; Solomon ER; Brainard JA; Barber MD
    Int Urogynecol J; 2015 Apr; 26(4):591-5. PubMed ID: 25377295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incontinence rates after midurethral sling revision for vaginal exposure or pain.
    Jambusaria LH; Heft J; Reynolds WS; Dmochowski R; Biller DH
    Am J Obstet Gynecol; 2016 Dec; 215(6):764.e1-764.e5. PubMed ID: 27448731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of vaginal mesh exposure after midurethral sling placement: a case-control study.
    Linder BJ; El-Nashar SA; Carranza Leon DA; Trabuco EC
    Int Urogynecol J; 2016 Sep; 27(9):1321-6. PubMed ID: 26811112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological findings in explanted vaginal mesh.
    Li L; Wang X; Park JY; Chen H; Wang Y; Zheng W
    Hum Pathol; 2017 Nov; 69():46-54. PubMed ID: 28970142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transvaginal sling excision: tips and tricks.
    Clifton MM; Goldman HB
    Int Urogynecol J; 2017 Jan; 28(1):155-156. PubMed ID: 27530521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of early postoperative voiding dysfunction and other complications following a midurethral sling.
    Ripperda CM; Kowalski JT; Chaudhry ZQ; Mahal AS; Lanzer J; Noor N; Good MM; Hynan LS; Jeppson PC; Rahn DD
    Am J Obstet Gynecol; 2016 Nov; 215(5):656.e1-656.e6. PubMed ID: 27319367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications and risk factors for midurethral sling revision.
    Unger CA; Rizzo AE; Ridgeway B
    Int Urogynecol J; 2016 Jan; 27(1):117-22. PubMed ID: 26134541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voiding dysfunction following removal of eroded synthetic mid urethral slings.
    Starkman JS; Wolter C; Gomelsky A; Scarpero HM; Dmochowski RR
    J Urol; 2006 Sep; 176(3):1040-4. PubMed ID: 16890687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for mesh erosion after vaginal sling procedures for urinary incontinence.
    Kokanali MK; Doğanay M; Aksakal O; Cavkaytar S; Topçu HO; Özer İ
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():146-50. PubMed ID: 24793930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant trocar-guided transvaginal mesh surgery with a midurethral sling in treating advanced pelvic organ prolapse associated with stress or occult stress urinary incontinence.
    Wu CJ; Chuang FC; Chu LC; Kung FT; Huang KH; Wu MP
    Taiwan J Obstet Gynecol; 2013 Dec; 52(4):516-22. PubMed ID: 24411036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous graft for treatment of midurethral sling exposure without mesh excision.
    Jeppson PC; Sung VW
    Obstet Gynecol; 2013 Feb; 121(2 Pt 2 Suppl 1):437-9. PubMed ID: 23344401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic mid-urethral sling complications: Evolution of presenting symptoms over time.
    Wang C; Christie AL; Zimmern PE
    Neurourol Urodyn; 2018 Aug; 37(6):1937-1942. PubMed ID: 29464783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative vaginal estrogen and midurethral sling exposure: a retrospective cohort study.
    Cadish LA; West EH; Sisto J; Longoria T; Bebchuk JD; Whitcomb EL
    Int Urogynecol J; 2016 Mar; 27(3):413-7. PubMed ID: 26264475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the local carcinogenic potential of mesh used in the treatment of female stress urinary incontinence.
    Linder BJ; Trabuco EC; Carranza DA; Gebhart JB; Klingele CJ; Occhino JA
    Int Urogynecol J; 2016 Sep; 27(9):1333-6. PubMed ID: 26864666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique case of suburethral sling mesh migration to the cervix.
    Mazloomdoost D; Pauls RN
    Int Urogynecol J; 2016 Nov; 27(11):1775-1776. PubMed ID: 27631822
    [No Abstract]   [Full Text] [Related]  

  • 16. Normal preoperative urodynamic testing does not predict voiding dysfunction after Burch colposuspension versus pubovaginal sling.
    Lemack GE; Krauss S; Litman H; FitzGerald MP; Chai T; Nager C; Sirls L; Zyczynski H; Baker J; Lloyd K; Steers WD;
    J Urol; 2008 Nov; 180(5):2076-80. PubMed ID: 18804239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of voiding after sling: a randomized trial of 2 methods of postoperative catheter management after midurethral sling surgery for stress urinary incontinence in women.
    Tunitsky-Bitton E; Murphy A; Barber MD; Goldman HB; Vasavada S; Jelovsek JE
    Am J Obstet Gynecol; 2015 May; 212(5):597.e1-9. PubMed ID: 25434837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent pelvic pain following transvaginal mesh surgery: a cause for mesh removal.
    Marcus-Braun N; Bourret A; von Theobald P
    Eur J Obstet Gynecol Reprod Biol; 2012 Jun; 162(2):224-8. PubMed ID: 22464208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "J" cut of sling for postoperative voiding dysfunction following synthetic midurethral slings.
    Kasturi S; Hale DS
    Int Urogynecol J; 2011 Aug; 22(8):933-6. PubMed ID: 21461708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of transurethral resection (TUR) of intravesical mesh after suburethral slings in the treatment of urinary stress incontinence.
    Castroviejo-Royo F; Rodríguez-Toves LA; Martínez-Sagarra-Oceja JM; Conde-Redondo C; Mainez-Rodríguez JA
    Actas Urol Esp; 2015 Apr; 39(3):183-7. PubMed ID: 25457565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.